Document is current
Any future updates will be listed below
-
Authors
Johns, Andrew C. https://orcid.org/0000-0001-9821-8662
Yang, Mike
Wei, Lai https://orcid.org/0000-0002-7248-3828
Grogan, Madison
Patel, Sandipkumar H.
Li, Mingjia https://orcid.org/0000-0002-3910-4179
Husain, Marium https://orcid.org/0000-0003-2649-1154
Kendra, Kari L.
Otterson, Gregory A.
Burkart, Jarred T.
Spakowicz, Daniel https://orcid.org/0000-0003-2314-6435
Hoyd, Rebecca https://orcid.org/0000-0003-1210-4491
Owen, Dwight H. https://orcid.org/0000-0002-6598-4886
Presley, Carolyn J. https://orcid.org/0000-0002-2607-5639
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002733)
National Institute of Aging (1K76AG074923-01;R03AG064374)
National Institutes of Health (P30 CA016058)
- License Information
-
More Information
Article History
Received: 24 June 2022
Accepted: 6 January 2023
First Online: 4 February 2023
Declarations
:
: Gregory Otterson reports speaker honoraria from OncLive and NCCN. He reports institution-directed research funding from: Roche/Genentech, AstraZeneca, BMS, Merck, AbbVie, and Elevation Oncology. Dwight Owen reports institution-directed research funding from BMS, Merck, Palobiofarma, Genentech, Pfizer, and Onc.AI.
